相关实验视频

Updated: Jan 9, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

系统性miR-26a缺乏通过PTEN上调和下游TIMP-1抑制减轻肺纤维化

Arisa Hamada¹, Kiyofumi Shimoji¹, Taku Nakashima¹

¹Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Molecular therapy. Nucleic acids

|December 1, 2025

概括

系统性微RNA-26a (miR-26a) 缺乏会减少小鼠肺纤维化. 失去miR-26a通过增加PTEN来抑制纤维化通路,这与之前报告的抗纤维化作用相反.

科学领域:

分子生物学分子生物学
细胞生物学细胞生物学
遗传学是一个遗传学.

背景情况:

微RNA (miRNA) 在肺纤维化中起作用,但机制尚不清楚.
据报道,当气道表达低时,miR-26a具有抗纤维菌作用.
缺乏miR-26a对肺纤维化的系统性影响尚不清楚.

研究的目的:

研究系统性miR-26a缺乏在肺纤维化中的作用.
阐明 miR-26a 对纤维化的作用背后的分子机制.

主要方法:

使用miR-26a淘汰赛 (KO) 和野生型 (WT) 鼠标模型.
进行全肺RNA测序以分析信号通路.
在初级肺纤维细胞中研究基因表达 in vitro.

主要成果:

与WT小鼠相比,miR-26aKO小鼠显示肺纤维化减少.
在WT小鼠中,MTORC1和PI3K/AKT信号通路升高.
失去miR-26a增加了PTEN表达,减少TIMP1和减弱纤维化.
在体外,miR-26a通过抑制PTEN和增加TIMP1和ACTA2促进纤维化.

结论:

系统性miR-26a缺乏减轻了肺纤维化,这与之前的发现相反.
miR-26a通过向PTEN促进纤维化,影响PI3K/Akt-mTOR通路.
局部和全身抑制miR-26a可能具有相反的效果,需要仔细制定治疗策略.

关键词:

MT:非编码RNAs的使用.在这里,我们可以使用PTEN.在TIMP-1中使用.在 miR-26a 系统中.这是一个微型RNA.肺部纤维化肺部纤维化

更多相关视频

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...